GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (XTER:PFE) » Definitions » Long-Term Debt

Pfizer (XTER:PFE) Long-Term Debt : €51,283 Mil (As of Sep. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Pfizer Long-Term Debt?

Pfizer's Long-Term Debt for the quarter that ended in Sep. 2024 was €51,283 Mil.

Pfizer's quarterly Long-Term Debt declined from Mar. 2024 (€55,639 Mil) to Jun. 2024 (€52,705 Mil) and declined from Jun. 2024 (€52,705 Mil) to Sep. 2024 (€51,283 Mil).

Pfizer's annual Long-Term Debt declined from Dec. 2021 (€30,760 Mil) to Dec. 2022 (€30,137 Mil) but then increased from Dec. 2022 (€30,137 Mil) to Dec. 2023 (€55,478 Mil).

Pfizer Long-Term Debt Historical Data

The historical data trend for Pfizer's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfizer Long-Term Debt Chart

Pfizer Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31,185.00 29,239.36 30,759.95 30,137.20 55,477.58

Pfizer Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57,201.98 55,477.58 55,638.84 52,704.96 51,283.12

Pfizer  (XTER:PFE) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Pfizer Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Pfizer's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Pfizer Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (XTER:PFE) » Definitions » Long-Term Debt
Comparable Companies
AMGN BMY GILD MRK BIIB OGN AMRN SCLX MIRA ABBV LLY OCSE:NOVO B JNJ XSWX:ROG XSWX:NOVN LSE:AZN XPAR:SAN LSE:GSK TSE:4519 TSE:4568
Traded in Other Exchanges
PFE:USA PFE:Peru PFE:Mexico PFE_KZ:Kazakhstan 1PFE:Italy PFEd:UK PFEB:Germany PFE:Germany PFE:Germany PFE:Germany PFE:Canada PFIZ34:Brazil PFE:Bulgaria PFE:Austria PFE:Argentina
Address
66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Website
https://www.pfizer.com
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.